Cargando…

Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment

Detalles Bibliográficos
Autores principales:	Xia, Xianghou, Ye, Zu, Ahmad, Sajjad, Wei, Yongkun, Yu, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374327/ https://www.ncbi.nlm.nih.gov/pubmed/37521475 http://dx.doi.org/10.3389/fphar.2023.1252168

Ejemplares similares

Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway
por: Qin, Chengdong, et al.
Publicado: (2023)

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
por: Zhai, Jiaqi, et al.
Publicado: (2023)

Bibliometric analysis of research on immunogenic cell death in cancer
por: Zhou, Yan, et al.
Publicado: (2022)

Editorial: The roles of ion-induced cell death in cancer treatment: volume II
por: Zhang, Kui, et al.
Publicado: (2023)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Editorial: Women in pharmacology of anti-cancer drugs: 2021
por: Giovannetti, Elisa
Publicado: (2022)

Editorial: Insights in pharmacology of anti‐cancer drugs: 2021
por: Sancho, Patricia, et al.
Publicado: (2022)

Editorial: Different cell death modes in cancer treatment
por: Bai, Zhaoshi, et al.
Publicado: (2023)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
por: Khan, Husain Yar, et al.
Publicado: (2023)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Editorial: Anti-cancer effects of botanical drugs targeting the tumor microenvironment
por: Cheng, Chien-shan, et al.
Publicado: (2023)

Editorial: structural plasticity induced by drugs of abuse
por: Olive, M. Foster, et al.
Publicado: (2015)

PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis
por: He, Yun, et al.
Publicado: (2022)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015)

Editorial: Drug re-purposing for the treatment of bacterial infections
por: Tomás, María, et al.
Publicado: (2022)

Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
por: Li, Xiaohui, et al.
Publicado: (2022)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Editorial: Potential of natural products as drug leads possessing antioxidant and anti-aging properties
por: Youssef, Fadia S., et al.
Publicado: (2022)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases
por: Zhang, Qiuwang, et al.
Publicado: (2023)

Editorial: Natural compounds as scaffolds for the discovery of new anti-cancer drugs: Focus on terpenoids and flavonoids
por: Sülsen, Valeria P., et al.
Publicado: (2022)

Editorial: Medicinal plants as a source of novel autoimmune-modulating and anti-inflammatory drug products
por: Wang, Yang, et al.
Publicado: (2022)

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
por: Wang, Zhi-Bin, et al.
Publicado: (2023)

Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma
por: Xiang, Jiankang, et al.
Publicado: (2023)

Editorial: Molecular imaging for tracking drug delivery
por: Han, Zheng, et al.
Publicado: (2023)

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
por: Ramsay, Rona R., et al.
Publicado: (2017)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Editorial: Advances in Drug Formulation
por: Mukherjee, Biswajit, et al.
Publicado: (2020)

Editorial: Pharmacokinetics of herbal medicines and herb-drug interactions
por: Jia, Wei-Wei, et al.
Publicado: (2022)

Editorial: Natural products targeting oxidative stress and cell death: Treatment potential in metabolic and cardiovascular diseases
por: Kosuru, Ramoji, et al.
Publicado: (2023)

Editorial: The practical implication of clinical pharmacokinetics in drug development, pharmaceutical analysis, and clinical research
por: Khan, Abad, et al.
Publicado: (2023)

Editorial: Therapeutic strategies for drug-induced liver injury: Review of the current literature
por: Robles-Díaz, Mercedes, et al.
Publicado: (2022)

Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes
por: Rasouli, Hassan, et al.
Publicado: (2023)

Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
por: Moldasheva, Aiman, et al.
Publicado: (2022)

Editorial: Advanced nanotechnological detection and drug delivery configurations
por: Hashemi, Seyyed Alireza, et al.
Publicado: (2023)

Editorial: Emerging talents in pharmacology: Drugs outcomes research and policies 2022
por: Linger, Rachel M. A., et al.
Publicado: (2023)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bsc2rubojnh6il397d5tasitft